Purple Innovation Reports Lower Net Loss and Positive Adjusted EBITDA in Q3 2025

Reuters11-05
Purple Innovation Reports Lower Net Loss and Positive Adjusted EBITDA in Q3 2025

Purple Innovation Inc. reported a net loss of $11.7 million for the third quarter ended September 30, 2025, an improvement from a net loss of $39.2 million in the same period last year. Adjusted EBITDA was $0.2 million, up from $(6.4) million a year earlier. Operating expenses decreased to $63.0 million from $82.0 million, primarily due to reduced restructuring, impairment, and related charges. Adjusted operating expenses were $57.7 million, down by $5.4 million from the prior year. As of September 30, 2025, cash and cash equivalents were $32.4 million, compared to $29.0 million at the end of 2024. Key business developments included continued progress with the Rejuvenate 2.0 initiative and the ongoing rollout with Mattress Firm to support growth in the premium segment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Purple Innovation Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-106084), on November 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment